```html
Market SnapshotTakeaway:
(SUPN.O) remains in a state of technical neutrality, with mixed analyst ratings and strong money inflows.
News Highlights May 31, 2025: Trump's aggressive tariff policy continues to cause uncertainty in global markets, especially for sectors like pharmaceuticals and manufacturing. This could affect Supernus' operating environment if it relies on international supply chains or exports. May 29, 2025: Changes in U.S. COVID-19 vaccine policy could impact Supernus, especially if it has any pipeline assets in the respiratory or biotech space. The restructured approval process might affect regulatory timelines and investor sentiment. May 31, 2025: REX Shares plans
and
ETFs that may bypass SEC hurdles using a C-corp structure. While not directly related, this highlights broader regulatory flexibility that might benefit Supernus if it has exposure to biotech or life sciences innovation.
Analyst Views & Fundamentals
The analyst consensus for Supernus shows a simple average rating of 4.67 and a performance-weighted rating of 1.46, indicating that while the average rating is moderate, the historical performance of the analysts involved is mixed to poor. Rating Consistency: Analyst ratings are dispersed—two "Strong Buy" and one "Buy" in the last 20 days. The market consensus is pessimistic, especially given recent price declines. Historical Analyst Performance: Piper Sandler (David Amsellem): 100.0% historical win rate, 7.35% average return—most optimistic and historically accurate. TD Cowen (Stacy Ku) and B of A Securities (Pavan Patel): 0.0% historical win rate with negative average returns—caution advised. Price Trend vs. Analyst Expectations: The current price trend has been down (-9.44%), which aligns with the weighted pessimism of the analysts. Fundamentals: No key fundamental factors were available for direct analysis.
Money-Flow TrendsSupernus has seen positive fund-flow patterns across all investor sizes, with inflow ratios consistently above 50%: Overall Inflow Ratio: 51.80% Block (Large) Inflow Ratio: 51.88% Small Inflow Ratio: 52.66%This suggests that both retail and institutional investors are showing interest in the stock. The fund-flow score is 7.95 (internal diagnostic score, 0-10), which we consider "good" and indicates positive overall money movement.
Key Technical SignalsSupernus is currently in a technical neutrality phase, with an internal technical score of 5.35 (internal diagnostic score, 0-10). This suggests that the market is in a volatile state with no clear direction. RSI Overbought: Score: 7.23 (internal diagnostic score, 0-10) – indicates bullish
. MACD Golden Cross: Score: 7.07 – another strong bullish indicator recently. WR Overbought: Score: 2.89 – neutral to slightly bearish. Long Lower Shadow: Score: 2.61 – neutral with a slight bias toward bearish. Marubozu White: Score: 6.97 – neutral with a bullish tendency.

Recent Indicators (Last 5 Days) 2025-10-29: WR Overbought, RSI Overbought, and Long Lower Shadow – suggesting conflicting signals with some volatility. 2025-10-28: RSI Overbought – continued bullish momentum. 2025-10-24: WR Overbought, RSI Overbought, and Marubozu White – mixed to bullish. 2025-10-30: WR Overbought, RSI Overbought – consistent overbought conditions. 2025-10-20: WR Overbought, RSI Overbought, and MACD Golden Cross – bullish crossover event.
Key Insights: Technical indicators suggest volatility without a clear trend. Long and short signals are balanced, and it's recommended to watch for further market movement to determine the next direction.
ConclusionSupernus is in a technical holding pattern, with conflicting analyst ratings and mixed fundamental signals. However, money is flowing in across all investor sizes, and technical indicators show potential for a bullish breakout, especially with the RSI and MACD showing strength.
Actionable Takeaway: Investors should consider waiting for a clearer breakout pattern or a pull-back before entering a position, particularly given the current technical neutrality and mixed analyst outlook.
```
Comments
No comments yet